Answer
People carrying HLA-B*5701 have a high risk of serious abacavir hypersensitivity and must not start an abacavir-containing product.
Sources for this answer
- Abacavir/Lamivudine Dr. Reddy's 600 mg/300 mg Film-Coated Tablets — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.